Neurontin indication

Psychiatric Medications - The

Psychiatric Medications - The Gabapentin Brand Name: Neurontin Overview Neurontin is the brand name for gabapentin, also known as GBP, an anticonvulsant medication. Brand Name Neurontin. Overview Neurontin is the brand name for gabapentin. It is frequently used with other medications to control symptoms of epilepsy.

<i>Neurontin</i>® gabapentin

Neurontin® gabapentin Initial: 150 mg/day PO divided q12hr; may increase within 1 week to 300 mg/day PO divided q12hr If there is insufficient pain relief after 2-3 weeks and 300 mg/day dose is tolerated, may increase dose again up to 600 mg/day PO divided q12hr Safety and efficacy not established A 15-week, placebo-controlled trial (n=107) was conducted in pediatric patients with fibromyalgia aged 12-17 yr with pregabalin (75-450 mg/day) The primary efficacy endpoint of change from baseline to Week 15 in mean pain intensity (derived from an 11-point numeric rating scale) showed numeriy greater improvement for the pregabalin-treated patients compared to placebo-treated patients, but did not reach statistical snificance Discontinue gradually over at least 1 week Monitor for physical dependence and withdrawal symptoms Monitor for decreased platelet count (rare) and increased creatinine kinase levels May cause prolongation of PR interval May potentiate effects of other sedatives Rhabdomyolysis reported (monitor for muscle pain) History of angioedema, concurrency with drugs associated with angioedema risk (eg, ACEIs) Increased risk of peripheral edema, dizziness, somnolence, blurred vision, and weht gain Potential risk of male-mediated teratogenicity Use caution in cardiovascular disease (heart failure) and renal impairment May impair ability to drive or perform hazardous tasks Discontinue treatment if hypersensitivity occurs Do not discontinue anticonvulsants abruptly as that may increase seizure frequency Antiepileptic drugs increase risk of suicidal thoughts or behavior in patients taking these drugs for any indication; monitor for emergence or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior Precise mechanism of action unknown but is a GABA analogue that binds to a subunit of voltage-gated calcium channels in CNS; does not affect sodium channels, opiate receptors, or cyclo-oxygenase enzyme activity; interactions with descending noradrenergic and serotonergic pathways orinating from the brain stem appear to reduce neuropathic pain transmission from spinal cord The above information is provided for general informational and educational purposes only. NEURONTIN - gabapentin capsule NEURONTIN - gabapentin tablet. increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication.

<i>Neurontin</i> gabapentin - Food and Drug

Neurontin gabapentin - Food and Drug Medscape uses cookies to customize the site based on the information we collect at registration. Neurontin gabapentin Audience Neuropsychiatric healthcare professionals, pharmacists and consumers. Pfizer Inc. and FDA notified healthcare.

Treatment of Neuropathic Pain -

Treatment of Neuropathic Pain - It is also indicated in over 50 countries for the adjunctive treatment of epilepsy and a range of neuropathic pain conditions. Gabapentin Neurontin®, Pfizer Pharmaceuticals. Treatment of neuropathic pain an overview of recent guidelines. Am J Med 2009;12210, SupplS22-S32.

Neurontin indication:

Rating: 95 / 100

Overall: 93 Rates

Добавить комментарий

Ваш e-mail не будет опубликован. Обязательные поля помечены *